0

Liver Disease Collection
 121-140 of 972 Articles
Screening |  1 December 1998
Prevalence of Hereditary Hemochromatosis in 16 031 Primary Care Patients
Pradyumna D. Phatak, MD; Ronald L. Sham, MD; Richard F. Raubertas, PhD; et al.
Ann Intern Med. 1998;129(11_Part_2):954-961. doi:10.7326/0003-4819-129-11_Part_2-199812011-00006
Screening |  1 December 1998
Iron Overload, Public Health, and Genetics: Evaluating the Evidence for Hemochromatosis Screening
Mary E. Cogswell, DrPH; Sharon M. McDonnell, MD, MPH; Muin J. Khoury, MD, PhD; et al.
Ann Intern Med. 1998;129(11_Part_2):971-979. doi:10.7326/0003-4819-129-11_Part_2-199812011-00008
Brief Communications |  15 November 1998
Oral Thymic Extract for Chronic Hepatitis C in Patients Previously Treated with Interferon: A Randomized, Double-Blind, Placebo-Controlled Trial
Robert S. Raymond, MD; Michael B. Fallon, MD; Gary A. Abrams, MD
Ann Intern Med. 1998;129(10):797-800. doi:10.7326/0003-4819-129-10-199811150-00009
Reviews |  15 October 1998
Treatment of Hepatocellular Carcinoma Associated with Cirrhosis in the Era of Liver Transplantation
Eytan Mor, MD; Ran Tur Kaspa, MD; Patricia Sheiner, MD; et al.
Ann Intern Med. 1998;129(8):643-653. doi:10.7326/0003-4819-129-8-199810150-00013
Brief Communications |  1 September 1998
Exhaled Nitric Oxide and Impaired Oxygenation in Cirrhotic Patients before and after Liver Transplantation
Giovanni Rolla, MD; Luisa Brussino, MD; Paola Colagrande, MD; et al.
Ann Intern Med. 1998;129(5):375-378. doi:10.7326/0003-4819-129-5-199809010-00005
Ideas and Opinions |  15 August 1998
Treating Histologically Mild Chronic Hepatitis C: Monotherapy, Combination Therapy, or Tincture of Time?
Robert A. Levine, MD
Ann Intern Med. 1998;129(4):323-326. doi:10.7326/0003-4819-129-4-199808150-00010
Articles |  15 July 1998
Relation of Interferon Therapy and Hepatocellular Carcinoma in Patients with Chronic Hepatitis C
Yasuharu Imai, MD; Sumio Kawata, MD; Shinji Tamura, MD; et al.
Ann Intern Med. 1998;129(2):94-99. doi:10.7326/0003-4819-129-2-199807150-00005
Articles |  1 July 1998
Surgery for Recurrent Colon Cancer: Strategies for Identifying Resectable Recurrence and Success Rates after Resection
Richard M. Goldberg, MD; Thomas R. Fleming, PhD; Catherine M. Tangen, DrPH; et al.
Ann Intern Med. 1998;129(1):27-35. doi:10.7326/0003-4819-129-1-199807010-00007
Brief Communications |  1 July 1998
Two Cases of Severe Clinical and Histologic Hepatotoxicity Associated with Troglitazone
Norman Gitlin, MD; Neil L. Julie, MD; Charles L. Spurr, MD; et al.
Ann Intern Med. 1998;129(1):36-38. doi:10.7326/0003-4819-129-1-199807010-00008
Brief Communications |  1 July 1998
Troglitazone-Induced Hepatic Failure Leading to Liver Transplantation: A Case Report
Brent A. Neuschwander-Tetri, MD; William L. Isley, MD; Julie C. Oki, PharmD; et al.
Ann Intern Med. 1998;129(1):38-41. doi:10.7326/0003-4819-129-1-199807010-00009
Articles |  15 May 1998
Incidence of Hepatitis C in Patients Receiving Different Preparations of Hepatitis B Immunoglobulins after Liver Transplantation
Cyrille Feray, MD, PhD; Michele Gigou, MD; Didier Samuel, MD, PhD; et al.
Ann Intern Med. 1998;128(10):810-816. doi:10.7326/0003-4819-128-10-199805150-00003
Articles |  1 March 1998
Screening for Hemochromatosis and Iron Deficiency in Employees and Primary Care Patients in Western Germany
Claus Niederau, MD; Christoph M. Niederau, MD; Stefan Lange, MD; et al.
Ann Intern Med. 1998;128(5):337-345. doi:10.7326/0003-4819-128-5-199803010-00001
Brief Communications |  1 March 1998
Severe Hyperbilirubinemia after Creation of Transjugular Intrahepatic Portosystemic Shunts: Natural History and Predictors of Outcome
Smita S. Rouillard, MD; Nathan M. Bass, MD, PhD; John P. Roberts, MD; et al.
Ann Intern Med. 1998;128(5):374-377. doi:10.7326/0003-4819-128-5-199803010-00006
Brief Communications |  15 January 1998
Serious Hepatitis A: An Analysis of Patients Hospitalized during an Urban Epidemic in the United States
Ira R. Willner, MD; Mark D. Uhl, MD; Scott C. Howard, MD; et al.
Ann Intern Med. 1998;128(2):111-114. doi:10.7326/0003-4819-128-2-199801150-00006
Brief Communications |  1 December 1997
Reversibility of Hepatic Fibrosis in Autoimmune Hepatitis
Jean-Francois Dufour, MD; Ronald DeLellis, MD; Marshall M. Kaplan, MD
Ann Intern Med. 1997;127(11):981-985. doi:10.7326/0003-4819-127-11-199712010-00006
Brief Communications |  1 December 1997
Effect of Fluoroquinolone on the Enhanced Nitric Oxide-Induced Peripheral Vasodilation Seen in Cirrhosis
Jaye P.F. Chin-Dusting, PhD; Brindi Rasaratnam, MBBS; Garry L.R. Jennings, MD, FRACP; et al.
Ann Intern Med. 1997;127(11):985-988. doi:10.7326/0003-4819-127-11-199712010-00007
Articles |  15 November 1997
Estimates of the Cost-Effectiveness of a Single Course of Interferon-α2b in Patients with Histologically Mild Chronic Hepatitis C
William G. Bennett, MD; Yuji Inoue, MD; J. Robert Beck, MD; et al.
Ann Intern Med. 1997;127(10):855-865. doi:10.7326/0003-4819-127-10-199711150-00001
Articles |  15 November 1997
Cost-Effectiveness of 6 and 12 Months of Interferon-α Therapy for Chronic Hepatitis C
W. Ray Kim, MD, MBA; John J. Poterucha, MD; John E. Hermans, BS; et al.
Ann Intern Med. 1997;127(10):866-874. doi:10.7326/0003-4819-127-10-199711150-00002
Articles |  15 November 1997
Long-Term Histologic Improvement and Loss of Detectable Intrahepatic HCV RNA in Patients with Chronic Hepatitis C and Sustained Response to Interferon-α Therapy
Patrick Marcellin, MD; Nathalie Boyer, MD; Anne Gervais, MD; et al.
Ann Intern Med. 1997;127(10):875-881. doi:10.7326/0003-4819-127-10-199711150-00003
Editorials |  15 November 1997
Interferon-α for Chronic Hepatitis C: Reducing the Uncertainties
Raymond S. Koff, MD
Ann Intern Med. 1997;127(10):918-920. doi:10.7326/0003-4819-127-10-199711150-00011
Advertisement
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)